Your session is about to expire
← Back to Search
CAR T-Cell Therapy for Non-Hodgkin's Lymphoma
Study Summary
This trial will test if a new cancer treatment can be given safely to patients outside of a hospital.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are participants still being accepted for this clinical experiment?
"This medical study is still enrolling participants according to information available on clinicaltrials.gov, which initially posted the trial in December of 2021 and revised it last September."
What is the uppermost capacity of participants in this experiment?
"Affirmative. According to clinicaltrials.gov, the trial – which was posted on December 2nd 2021 – is actively recruiting patients today. Currently, 20 individuals are being recruited from a single medical centre."
Is there an opportunity to enroll in this experiment?
"This trial is seeking to enrol 20 individuals, aged 18-75 years old, who have been diagnosed with large B cell lymphoma. To qualify for the study, applicants need to meet a set of criteria including: being in an ECOG performance status between 0 and 2; having neutrophils (ANC) greater than 1000/µL and platelets more than 75000/ µL; bilirubin lower than 1.5 mg/dL ;creatinine clearance higher or equal 60 mL per min per 1.73 m2; cardiac ejection fraction no less 50%; must be chemotherapy refractory disease evidenced by"
Is this experimental program open to adults aged 35 and older?
"According to eligibility criteria, only participants aged between 18 and 75 are applicable for this clinical trial. There are 305 studies aiming at younger individuals while 1612 trials focus on those over 65 years old."
Share this study with friends
Copy Link
Messenger